Guggenheim Securities
About Guggenheim Securities
Guggenheim Securities is the investment banking and capital markets arm of Guggenheim Partners. It provides premier strategic advisory, tailored financing solutions, and market insights through its research and sales & trading capabilities, serving clients globally with a focus on M&A, capital raisings, and complex transactions. The firm emphasizes independence in its advisory work and operates across advisory, financing, and research across multiple industries. Headquartered in the United States, it serves clients worldwide including corporate and financial sponsor clients.
Recent News
Parker‑Hannifin to Buy KKR‑Owned Circor Aerospace for $2.55 B
Arxis Prices Upsized $1.13 B IPO, Goldman, Morgan Stanley Lead Syndicate
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at ASCO Transcript
EXEC: Academy Sports Scores Stock Price Upgrades Following Analyst Day
BioNTech’s Multi-Modality Play Outpaces Moderna’s mRNA-Focused Pipeline
Avalyn Pharma Prices $300 Million IPO at $18 per Share, Expanding Biotech B2B Financing
The IPO Buzz: Generate Biomedicines (GENB Proposed) Launches $400 Million IPO
Yesway Files for Nasdaq IPO
Neurocrine Biosciences to Acquire Soleno Therapeutics for $2.9 Billion in Cash
Molina Healthcare, Inc. (MOH) Analyst/Investor Day Transcript
JATT II Acquisition Corp. (JATT) Prices $60M IPO
Grain Invests in Owner of Prime Data Centers
Lilly Eyes Pipeline in a Product as GLP-1s Move Into I&I